Boule Diagnostics (Sweden) Insiders
| BOUL Stock | SEK 7.38 0.62 9.17% |
Boule Diagnostics employs about 200 people. The company is managed by 10 executives with a total tenure of roughly 6 years, averaging almost 0.0 years of service per executive, having 20.0 employees per reported executive. Breaking down Boule Diagnostics' management performance can provide insight into the firm performance.
| Annette Colin Insider VP CFO |
| Helena Borjesson Insider Chief Officer |
Boule |
Boule Diagnostics Management Team Effectiveness
The company has return on total asset (ROA) of 0.0271 % which means that it generated a profit of $0.0271 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0335 %, meaning that it generated $0.0335 on every $100 dollars invested by stockholders. Boule Diagnostics' management efficiency ratios could be used to measure how well Boule Diagnostics manages its routine affairs as well as how well it operates its assets and liabilities.Boule Diagnostics Workforce Comparison
Boule Diagnostics AB is number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 1,309. Boule Diagnostics retains roughly 200 in number of employees claiming about 15% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.02 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.05 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.05. Boule Diagnostics Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Boule Diagnostics Price Series Summation is a cross summation of Boule Diagnostics price series and its benchmark/peer.
Boule Diagnostics Notable Stakeholders
A Boule Diagnostics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Boule Diagnostics often face trade-offs trying to please all of them. Boule Diagnostics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Boule Diagnostics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Kiarash Farr | Director of Commercial Operations | Profile | |
| Annette Colin | VP CFO | Profile | |
| Helena Borjesson | Chief Officer | Profile | |
| Karen Bornstein | North Marketing | Profile | |
| Aishat Bislieva | VP Culture | Profile | |
| Jesper Soderqvist | CEO Pres | Profile | |
| Mikael Ekholm | VP Production | Profile | |
| Michael Eliott | Head Consumables | Profile | |
| Mattias Isaksson | VP Marketing | Profile | |
| Christina Hugosson | Head Systems | Profile |
About Boule Diagnostics Management Performance
The success or failure of an entity such as Boule Diagnostics often depends on how effective the management is. Boule Diagnostics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Boule management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Boule management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Boule Diagnostics AB , a diagnostics company, develops, manufactures, and markets instruments and consumable products for blood diagnostics. Boule Diagnostics AB was founded in 1956 and is headquartered in Spnga, Sweden. Boule Diagnostics operates under Image Processing classification in Sweden and is traded on Stockholm Stock Exchange.
Please note, the imprecision that can be found in Boule Diagnostics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Boule Diagnostics AB. Check Boule Diagnostics' Beneish M Score to see the likelihood of Boule Diagnostics' management manipulating its earnings.
Boule Diagnostics Workforce Analysis
Traditionally, organizations such as Boule Diagnostics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Boule Diagnostics within its industry.Boule Diagnostics Manpower Efficiency
Return on Boule Diagnostics Manpower
| Revenue Per Employee | 2.3M | |
| Revenue Per Executive | 46.3M | |
| Net Income Per Employee | 116.4K | |
| Net Income Per Executive | 2.3M | |
| Working Capital Per Employee | 325K | |
| Working Capital Per Executive | 6.5M |
Additional Tools for Boule Stock Analysis
When running Boule Diagnostics' price analysis, check to measure Boule Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boule Diagnostics is operating at the current time. Most of Boule Diagnostics' value examination focuses on studying past and present price action to predict the probability of Boule Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boule Diagnostics' price. Additionally, you may evaluate how the addition of Boule Diagnostics to your portfolios can decrease your overall portfolio volatility.